January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Coagulant Therapeutics Corporation
Initiated from assets licensed from Bayer AG, Coagulant is leveraging both its Coagulation Cascade and Biologics expertise to develop a portfolio of drugs for the treatment of acute bleeding and adjacent indications including sepsis.